Evidence map›Paper›PMID 34180546›Full record

ArticleAllergy2022

One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2.

Anna D J Korath, Jozef Janda, Eva Untersmayr, Milena Sokolowska, Wojciech Feleszko, Ioana Agache, Ahmed Adel Seida, Katrin Hartmann, Erika Jensen-Jarolim, Isabella Pali-Schöll

Abstract readConsensus Statement
In one paragraph

Article in Allergy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. The Concept of One Health for Allergic Diseases and Asthma.Allergy, asthma & immunology research · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anna D J KorathComparative Medicine, Interuniversity Messerli Research Institute, University of Veterinary Medicine and Medical University Vienna, Vienna, Austria.ORCID 0000-0002-6408-4157
Jozef JandaFaculty of Science, Charles University, Prague, Czech Republic.ORCID 0000-0001-9958-5683
Eva UntersmayrInstitute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-1963-499X
Milena SokolowskaSwiss Institute of Allergy and Asthma Research (SIAF),, University of Zurich, Zurich, Switzerland.ORCID 0000-0001-9710-6685
Wojciech FeleszkoDepartment of Paediatric Allergy and Pulmonology, The Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0001-6613-2012
Ioana AgacheTransylvania University, Brasov, Romania.ORCID 0000-0001-7994-364X
Ahmed Adel SeidaDepartment of Microbiology and Immunology, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt.
Katrin HartmannMedizinische Kleintierklinik, Zentrum für Klinische Tiermedizin, LMU, Munich, Germany.ORCID 0000-0002-5256-863X
Erika Jensen-JarolimComparative Medicine, Interuniversity Messerli Research Institute, University of Veterinary Medicine and Medical University Vienna, Vienna, Austria.ORCID 0000-0003-4019-5765
Isabella Pali-SchöllComparative Medicine, Interuniversity Messerli Research Institute, University of Veterinary Medicine and Medical University Vienna, Vienna, Austria.ORCID 0000-0003-2089-6011

Funding

European Academy of Allergy and Clinical Immunology (EAACI)
6 · The paper itself

Abstract

The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), evolved into a worldwide pandemic with massive effects on health, quality of life, and economy. Given the short period of time since the outbreak, there are several knowledge gaps on the comparative and zoonotic aspects of this new virus. Within the One Health concept, the current EAACI position paper dwells into the current knowledge on SARS-CoV-2's receptors, symptoms, transmission routes for human and animals living in close vicinity to each other, usefulness of animal models to study this disease and management options to avoid intra- and interspecies transmission. Similar pandemics might appear unexpectedly and more frequently in the near future due to climate change, consumption of exotic foods and drinks, globe-trotter travel possibilities, the growing world population, the decreasing production space, declining room for wildlife and free-ranging animals, and the changed lifestyle including living very close to animals. Therefore, both the society and the health authorities need to be aware and well prepared for similar future situations, and research needs to focus on prevention and fast development of treatment options (medications, vaccines).

Indexed as

COVID-19One HealthAnimalsHumansPandemicsQuality of LifeSARS-CoV-2companion animals and petscoronavirusdisease transmissionOne Health(reverse) zoonosis

Identifiers

PMID34180546
PMCPMC8441637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.